Target intelligence / Profile preview

Bacterial and fungal deoxyribonucleic acid (DNA)

Target
DNA
Molecular classification
Nucleic acid (IUPAC, 2023)
01

Overview

Bacterial and fungal deoxyribonucleic acid (DNA) constitutes the essential genetic material for microbial life, encoding all proteins and regulatory elements necessary for cellular function and replication (NIH, 2023). In bacteria, DNA is typically organized into a single circular chromosome and various plasmids, while fungal DNA is organized into linear chromosomes within a nucleus, similar to eukaryotes but with distinct regulatory sequences (Wikipedia, 2024). As a therapeutic target, microbial DNA is susceptible to agents that cause direct physical damage, such as strand breaks or cross-links, which halt the cell cycle and lead to microbial death (StatPearls, 2023). For example, nitroimidazole antibiotics like metronidazole are reduced within anaerobic bacteria to form reactive radicals that attack the DNA backbone (PubMed, 2022). In fungi, certain antimetabolites like flucytosine are converted into fraudulent nucleotides that incorporate into DNA or inhibit its synthesis, disrupting its integrity and function (DrugBank, 2024). The primary challenge in targeting DNA is achieving sufficient selectivity to spare host genomic DNA from similar damage, thereby minimizing the risk of secondary malignancies or organ toxicity (PubMed, 2021).

Other names
Microbial DNAProkaryotic DNAFungal DNAGenomic DNABacterial DNA
02

Mechanism of action

Induction of DNA strand breaks via reactive intermediates, intercalation between base pairs, and covalent cross-linking of DNA strands to prevent replication and transcription (StatPearls, 2023; NIH, 2024).

03

Biological functions

Genetic information storage (NIH, 2023)Replication (Nature, 2022)Transcription (Science, 2021)
04

Disease associations

Infection (WHO, 2023)Bacterial infection (CDC, 2023)Fungal infection (CDC, 2023)Sepsis (NIH, 2024)
05

Safety considerations

Genotoxicity in host cells (PubMed, 2021)Mutagenicity (NIH, 2023)Carcinogenicity (IARC, 2022)Antimicrobial resistance (WHO, 2023)
06

Interacting drugs

Metronidazole

6 more in the full profile.

07

Biomarkers

Microbial DNA load (PubMed, 2022)DNA fragmentation (StatPearls, 2023)Circulating cell-free DNA (cfDNA) (Nature, 2021)

Beyond the preview

Go deeper on Bacterial and fungal deoxyribonucleic acid (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial and fungal deoxyribonucleic acid (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call